“…This is especially important in the growing number of DR cases endemic in certain parts of the world where early diagnosis, risk management, and treatment are key to containing the spread. The Timika Score was first reported in 2010 and has showed strong association with sputum smear grade and early disease burden [8] , [9] , [10] ; however, its reported performance for treatment outcome has not been as strong [11] . Since earlier studies often focused on DS, it is imperative to reassess Timika Score especially in the context of endemic DR TB in many areas of the world.…”